SynBioBeta Speaker
Scott Fay
Ansa Biotechnologies
VP Informatics
Scott Fay leads the design, development, and support of software systems that power Ansa’s enzymatic DNA synthesis platform. Since joining the company in 2022, he has overseen the development of Ansa’s manufacturing execution system, encompassing LIMS, work order orchestration, quality control, biosecurity screening, sample packaging management, and integrated manufacturing and R&D analytics.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Scott
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
